Startup Concure Oncology in Mercer Island, Washington. The mission is to ease the burden for women facing early-stage breast cancer by providing an innovative new kind of radiation treatment option.
Concure Oncology was funded $2 million in capital to use the funds to grow its company and train new clinicians to bring this treatment option to even more women.
Said Scott Armstrong, CEO of Concure Oncology. This funding can build out their team and give women who have breast cancer a better and more effective form of treatment as they move forward.
Breast Microseed Treatment is a radiation therapy technique for early-stage breast cancer patients. Also known as low-dose-rate brachytherapy, based on a similar method proven successful in treating prostate cancer. This procedure, also known as low-dose-rate brachytherapy, is based on a matching process established to treat prostate cancer successfully. What identifies this treatment from regular radiation therapy is that it allows post-lumpectomy patients the chance to have a one-time, one-hour procedure. The more burdensome conventional radiation may last from three to six weeks and require daily visits to a radiation facility.
After a tumor removed, the procedure involves placing small titanium seeds filled with radioactive palladium in the patient’s body where cancer applied. These seeds, which are the size of a rice grain, release a short measure of radiation in the former tumor area, killing any cancerous cells that remain and preventing new ones from growing. Once entirely removed, the seeds become inactive, with no radioactivity remaining.
Scott Armstrong said this financing speaks to the excitement and momentum they have seen for this truly groundbreaking type of breast cancer therapy.
By: K. Tagura
Author statement:
Funded.com is the leading platform for accredited investors network worldwide. We monitor and provide updates on important funding events. Angel Investors and Venture Funding can be a key growth for a startup or existing business. Whether it is a first, second or third round financing having a strategic alliance with an Angel Investor or Venture Capital financing can propel a business to the next level and give the competitive edge.